RxDoctor Payments DataLook up a doctor →

Michael Heile, MD

Family Medicine · Cincinnati, OHNPI 1588628234

Payments from drug & device makers

$272,220in general payments, 2019–2025

Across 950 payments — averaging $286.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$134K
  • Dexcom, Inc.$45K
  • Abbott$23K
  • Insulet Corporation$21K
  • Johnson & Johnson$17K
  • Roche Diabetes Care GmbH$11K
  • plus $20K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk239$134,100
Dexcom, Inc.57$45,162
Abbott39$23,146
Insulet Corporation39$20,935
Johnson & Johnson52$17,362
Roche Diabetes Care GmbH5$11,286
Sanofi-aventis U.S. LLC65$9,545
AstraZeneca(2 entities)22$3,772
Lilly USA, LLC85$1,093
Corcept Therapeutics29$633
AbbVie(2 entities)43$552
Amgen(2 entities)32$519
Bayer20$344
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC20$305
Mannkind Corporation10$258
Boehringer Ingelheim17$249
Merck17$240
Tandem Diabetes Care, Inc.9$229
Xeris Pharmaceuticals, Inc.12$218
Amarin Pharma, Inc.12$207
Novartis9$162
Pfizer10$152
BETA Bionics, Inc.10$142
Esperion Therapeutics, Inc.9$136
Exact Sciences5$119
Astellas Pharma US Inc6$98
GSK7$97
Medtronic4$94
Lifescan, Inc.6$92
Sequel Med Tech, LLC5$92
Takeda Pharmaceuticals U.S.A., Inc.4$64
Otsuka America Pharmaceutical, Inc.3$61
Nestle Healthcare Nutrition Inc.3$59
Biohaven Pharmaceuticals, Inc.4$57
Teva Pharmaceuticals USA, Inc.3$53
Paratek Pharmaceuticals, Inc.3$47
Cranial Technologies, Inc3$46
Sanofi Pasteur Inc.2$42
Valeritas, Inc.2$39
Amphastar Pharmaceuticals, Inc.2$37
Avanir Pharmaceuticals, Inc.2$34
Grifols USA, LLC2$28
Genentech USA, Inc.2$26
Ascensia Diabetes Care US Inc.2$25
Senseonics, Incorporated2$25
Alk-abello, Inc1$23
Viiv Healthcare Company1$21
Gilead1$19
Sumitomo Pharma America, Inc.1$19
Eisai Inc.1$17
Ironshore Pharmaceuticals Inc.1$16
Lundbeck LLC1$15
Antares Pharma, Inc.1$15
Boston Scientific1$14
Scilex Pharmaceuticals Inc.1$13
Idorsia Pharmaceuticals US Inc1$13
Seqirus USA Inc1$13
Kowa Pharmaceuticals America, Inc.1$12
Sun Pharmaceutical Industries Inc.1$11
E.r. Squibb & Sons, L.L.C.1$11

How this compares

$272,220 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio →

Medicare billing

Part B allowed, 2024
$69,698
Medicare patients
263
Services billed
1,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Cincinnati

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →